J Daléry

4.3k total citations
106 papers, 3.2k citations indexed

About

J Daléry is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, J Daléry has authored 106 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Psychiatry and Mental health, 31 papers in Cognitive Neuroscience and 24 papers in Clinical Psychology. Recurrent topics in J Daléry's work include Schizophrenia research and treatment (35 papers), Treatment of Major Depression (14 papers) and Mental Health and Psychiatry (14 papers). J Daléry is often cited by papers focused on Schizophrenia research and treatment (35 papers), Treatment of Major Depression (14 papers) and Mental Health and Psychiatry (14 papers). J Daléry collaborates with scholars based in France, Tunisia and United States. J Daléry's co-authors include Thierry d’Amato, Mohamed Saoud, Nicolás Franck, M Marie-Cardine, N. Georgieff, Marc Jeannerod, Elena Daprati, Benoît Bediou, C. Farrer and Joëlle Proust and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Cognition.

In The Last Decade

J Daléry

102 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
J Daléry 1.7k 1.7k 499 499 483 106 3.2k
Thierry d’Amato 1.8k 1.1× 2.1k 1.3× 444 0.9× 530 1.1× 686 1.4× 125 4.0k
Ron Hijman 1.1k 0.6× 1.6k 1.0× 319 0.6× 404 0.8× 534 1.1× 50 3.5k
Jean‐Marie Danion 3.0k 1.8× 2.1k 1.2× 335 0.7× 582 1.2× 466 1.0× 174 4.8k
S. Kristian Hill 1.2k 0.7× 1.9k 1.1× 189 0.4× 286 0.6× 411 0.9× 81 2.9k
Armida Mucci 2.3k 1.4× 2.5k 1.5× 446 0.9× 735 1.5× 838 1.7× 157 4.8k
Wolfgang Wölwer 1.5k 0.9× 1.9k 1.2× 310 0.6× 636 1.3× 1.0k 2.2× 112 3.4k
Vaibhav A. Diwadkar 2.4k 1.4× 1.7k 1.0× 228 0.5× 257 0.5× 993 2.1× 149 4.6k
D.L. Braff 1.4k 0.8× 2.4k 1.5× 281 0.6× 870 1.7× 671 1.4× 18 3.4k
Jenifer L. Vohs 1.2k 0.7× 1.6k 1.0× 285 0.6× 847 1.7× 736 1.5× 80 3.0k
Ralph E. Hoffman 2.6k 1.6× 2.1k 1.2× 258 0.5× 747 1.5× 743 1.5× 67 4.9k

Countries citing papers authored by J Daléry

Since Specialization
Citations

This map shows the geographic impact of J Daléry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Daléry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Daléry more than expected).

Fields of papers citing papers by J Daléry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Daléry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Daléry. The network helps show where J Daléry may publish in the future.

Co-authorship network of co-authors of J Daléry

This figure shows the co-authorship network connecting the top 25 collaborators of J Daléry. A scholar is included among the top collaborators of J Daléry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Daléry. J Daléry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lerond, Jérôme, Amélie Lothe, Philippe Ryvlin, et al.. (2012). Effects of Aripiprazole, Risperidone, and Olanzapine on 5-HT1A Receptors in Patients With Schizophrenia. Journal of Clinical Psychopharmacology. 33(1). 84–89. 16 indexed citations
2.
Brunelin, Jérôme, Emmanuel Poulet, Benoît Bediou, et al.. (2007). Un déficit de mémoire de la source spécifique chez les patients schizophrènes comparés à des volontaires sains et des patients présentant un épisode dépressif majeur. European Review of Applied Psychology. 58(2). 105–110. 8 indexed citations
3.
Bediou, Benoît, Pierre Krolak‐Salmon, Mohamed Saoud, et al.. (2005). Facial Expression and Sex Recognition in Schizophrenia and Depression. The Canadian Journal of Psychiatry. 50(9). 525–533. 78 indexed citations
4.
Poulet, Emmanuel, Jérôme Brunelin, Jérôme Lerond, et al.. (2004). Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment. European Psychiatry. 19(6). 382–383. 36 indexed citations
5.
Poulet, Emmanuel, Jérôme Brunelin, Benoît Bediou, et al.. (2004). Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia. Biological Psychiatry. 57(2). 188–191. 124 indexed citations
7.
Daléry, J & Adriaan Honig. (2003). Fluvoxamine versus fluoxetine in major depressive episode: a double‐blind randomised comparison. Human Psychopharmacology Clinical and Experimental. 18(5). 379–384. 35 indexed citations
8.
Lôo, H., et al.. (2002). [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders].. PubMed. 28(2). 165–62. 47 indexed citations
9.
Saoud, Mohamed, et al.. (2002). Cannabis use correlates with schizotypal personality traits in healthy students. Psychiatry Research. 109(1). 27–35. 74 indexed citations
10.
Daléry, J, et al.. (2001). [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].. PubMed. 27(1). 71–81. 10 indexed citations
11.
Laurent, Annie, et al.. (2001). WCST performance and schizotypal features in the first-degree relatives of patients with schizophrenia. Psychiatry Research. 104(2). 133–144. 26 indexed citations
12.
Daléry, J, et al.. (2001). Efficacy of tianeptine vs placebo in the long-term treatment (16.5 months) of unipolar major recurrent depression. Human Psychopharmacology Clinical and Experimental. 16(S1). S39–S47. 13 indexed citations
13.
Vandel, Pierre, Émmanuel Haffen, S Vandel, et al.. (1999). Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypes. European Journal of Clinical Pharmacology. 55(9). 659–665. 38 indexed citations
14.
Franck, Nicolás, Elena Daprati, Michel François, et al.. (1998). Gaze discrimination is unimpaired in schizophrenia. Psychiatry Research. 81(1). 67–75. 31 indexed citations
15.
16.
Daléry, J, et al.. (1997). The efficacy and acceptability of amineptine versus fluoxetine in major depression. International Clinical Psychopharmacology. 12. S35–S38. 9 indexed citations
17.
d’Amato, Thierry, et al.. (1997). Cerebral investigation of healthy siblings of schizophrenics. European Psychiatry. 12(6). 273–278.
18.
Jordan, D. C., et al.. (1992). Disappearance of hypothalamic TRH asymmetry in suicide patients. Journal of Neural Transmission. 89(1-2). 103–110. 2 indexed citations
19.
Burloux, Gabriel, et al.. (1989). Chronic Pain and Posttraumatic Stress Disorders. Psychotherapy and Psychosomatics. 52(1-3). 119–124. 4 indexed citations
20.
Daléry, J, et al.. (1985). [Daily profiles of melatonin, cortisol and gonadotropins in 8 adolescents with anorexia nervosa].. PubMed. 11(1). 25–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026